Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials

Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease

(2013) Regina Kunz et al.   ANNALS OF INTERNAL MEDICINE

Design of Combination Angiotensin Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor for Treatment of Diabetic Nephropathy (VA NEPHRON-D)

(2009) L. F. Fried et al.   Clinical Journal of the American Society of Nephrology

Valsartan in combination with lisinopril versus the respective high dose monotherapies in hypertensive patients with microalbuminuria: the VALERIA trial

(2009) Jan Menne et al.   JOURNAL OF HYPERTENSION

Combining GFR and Albuminuria to Classify CKD Improves Prediction of ESRD

(2009) S. I. Hallan et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes

(2009) T. Ninomiya et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes

(2009) B. E. de Galan et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Retraction—Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

(2009) The Editors of The Lancet   LANCET

Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: A meta-analysis

(2008) Saravanan Balamuthusamy et al.   AMERICAN HEART JOURNAL

Effects of Renin-Angiotensin System Blockers on Renal Outcomes and All-cause Mortality in Patients With Diabetic Nephropathy: An Updated Meta-analysis

(2008) P. A. Sarafidis et al.   AMERICAN JOURNAL OF HYPERTENSION

Dual blockade of the rennin–angiotensin system versus maximal recommended dose of angiotensin II receptor blockade in chronic glomerulonephritis

(2008) Urara Mori-Takeyama et al.   Clinical and Experimental Nephrology

Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis

(2008) Gianpaolo Reboldi et al.   JOURNAL OF HYPERTENSION

Is There Added Value to Adding ARB to ACE Inhibitors in the Management of CKD?

(2008) D. L. Cohen et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The COOPERATE trial: a letter of concern

(2008) Regina Kunz et al.   LANCET

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

(2008)   LANCET

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

(2008) Johannes FE Mann et al.   LANCET

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

(2008)   NEW ENGLAND JOURNAL OF MEDICINE